GeoVax Reports 2021 Year-End Financial Results and Provides
Advancing Phase 2 Clinical Trials for COVID-19 and Immuno-Oncology  ATLANTA, GA, March 09, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax...
National Cancer Institute Emory University Drug Administration Geovax Labs Inc Therapeutics Inc Products Clinical Trials Grants Program
Source: globenewswire.com